Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural features important for sigma 1 receptor binding

R A Glennon1, S Y Ablordeppey, A M Ismaiel

  • 1Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0540.

Journal of Medicinal Chemistry
|April 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of study design on effects of mask wearing on fMRI BOLD contrast and systemic physiology - A comment on Law et al. (2021).

NeuroImage·2021
Same author

New series of fused pyrazolopyridines: Synthesis, molecular modeling, antimicrobial, antiquorum-sensing and antitumor activities.

Bioorganic chemistry·2019
Same author

Evaluation of SYA16263 as a new potential antipsychotic agent without catalepsy.

Pharmacology, biochemistry, and behavior·2019
Same author

Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters.

ACS chemical neuroscience·2015
Same author

Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats.

ACS chemical neuroscience·2015
Same author

Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues.

British journal of pharmacology·2014
Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026
Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026
Same journal

GID4-Recruiting PROTACs for BRD4 Degradation Overcome Resistance Driven by CRBN and VHL Deficiency.

Journal of medicinal chemistry·2026
Same journal

Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer.

Journal of medicinal chemistry·2026
Same journal

Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

Journal of medicinal chemistry·2026
Same journal

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
See all related articles

Researchers developed superpotent sigma 1 ligands using N-substituted phenylalkylamines. This research addresses challenges in sigma receptor studies by providing high-affinity agents and a binding model for sigma 1 sites.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • Sigma receptor research is hindered by a lack of high-affinity agents.
  • Multiple sigma receptor populations (sigma 1 and sigma 2) have been identified.
  • Superpotent sigma ligands (Ki < 1 nM) are crucial for advancing research.

Purpose of the Study:

  • To investigate structure-affinity relationships of N-substituted phenylalkylamines at sigma 1 receptors.
  • To identify novel superpotent sigma 1 ligands.
  • To develop a binding model for phenylalkylamine interactions with sigma 1 sites.

Main Methods:

  • Synthesis and characterization of N-substituted phenylalkylamine derivatives.
  • Radioligand binding assays to determine affinity (Ki values) for sigma 1 receptors.

Related Experiment Videos

  • Development of a computational binding model based on structure-activity relationships.

    • Main Results:

    • Several N-substituted phenylalkylamine derivatives exhibited high affinity for sigma 1 receptors.
    • Identified novel superpotent sigma 1 ligands with Ki values below 1 nM.
    • Established key structural features of phenylalkylamines critical for sigma 1 receptor binding.

    Conclusions:

    • N-substituted phenylalkylamines represent a promising class of compounds for developing superpotent sigma 1 ligands.
    • The developed binding model provides insights into the molecular interactions at sigma 1 sites.
    • This work contributes significantly to the field of sigma receptor pharmacology and drug discovery.